Rein Therapeutics (RNTX) Change in Cash (2016 - 2026)
Rein Therapeutics (RNTX) posted quarterly Change in Cash of $1.2 million for Q1 2026, up 122.62% year-over-year from $552504.1 in Q1 2025, and up 247.66% quarter-over-quarter from -$833000.0 in Q4 2025.
Rein Therapeutics (RNTX) Change in Cash (2016 - 2026) Analysis & Trends
Rein Therapeutics (RNTX) has reported Change in Cash for 11 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash rose 122.62% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at -$3.0 million (up 35.7% YoY), while the FY2025 annual figure was -$9.6 million, down 115.74% from the prior year.
- Change in Cash climbed to $1.2 million in Q1 2026 per RNTX's latest filing, from -$833000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $9.9 million in Q2 2024 and bottomed at -$5.4 million in Q1 2025.
- Historically, Change in Cash has averaged $48235.3 across 5 years, with a median of -$833000.0 in 2025.
- Annual changes were most pronounced in 2023 — Change in Cash jumped 2907.82% — and 2024, when it tumbled 303.59%.
- Rein Therapeutics' Change in Cash stood at $355000.0 in 2022, then soared by 1377.18% to $5.2 million in 2023, then slumped by 191.76% to -$4.8 million in 2024, then soared by 82.69% to -$833000.0 in 2025, then surged by 247.66% to $1.2 million in 2026.
- Business Quant data shows RNTX's Change in Cash at $1.2 million in Q1 2026, -$833000.0 in Q4 2025, and -$1.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Rein Therapeutics | 55.49 Mn | 55.49 Mn | - | 4.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.10 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | -833,000.00 |
| Sep 30, 2025 | -1.67 Mn |
| Jun 30, 2025 | -1.71 Mn |
| Mar 31, 2025 | -5.44 Mn |
| Dec 31, 2024 | -4.81 Mn |
| Sep 30, 2024 | -4.27 Mn |
| Jun 30, 2024 | 9.88 Mn |
| Mar 31, 2024 | -5.27 Mn |
| Dec 31, 2023 | 5.24 Mn |
| Sep 30, 2023 | -1.10 Mn |
| Jun 30, 2023 | 5.38 Mn |
| Mar 31, 2023 | 2.59 Mn |
| Dec 31, 2022 | 355,000.00 |
| Sep 30, 2022 | -2.79 Mn |
| Jun 30, 2022 | 179,000.00 |
| Mar 31, 2022 | 3.85 Mn |
| Dec 31, 2021 | -4.00 Mn |
| Sep 30, 2021 | -3.15 Mn |